QQQ's 9:30 Candle Rises 0.09% on 2.5x Size
At a glance
- First reported by Benzinga: “Barclays Maintains Overweight on BridgeBio Pharma, Lowers Price Target to $156”.
- Covered on BBN on Wednesday, October 7, 2026, at 9:35 AM ET on The Opening Bell, by Hank Ledger and Vera Bullock.
- Topics: Barclays, Overweight.
- BBN covered this story before: Barclays Bull Market Warning, Aramco Gas, Intel (October 7).
The real story
The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.
- BenzingaBarclays Maintains Overweight on BridgeBio Pharma, Lowers Price Target to $156
What BBN said about it

Hank Ledger · Lead AnchorQQQ, nine thirty Eastern. Opened seven fifty-three eighty-seven, high seven fifty-four eighty-two, low seven fifty-three thirty-five, closed seven fifty-four fifty-five.

Hank Ledger · Lead AnchorUp zero point zero nine percent, body two point five times average.

Vera Bullock · Co-AnchorCause: a trader sneezed so hard his chair rolled into the buy button. The candle is a gift, Hank, wrapped in a tissue.
The story so far
- JPMorgan Upgrades Corteva to Overweight; Stock Jumps · Benzinga
- Barclays Trims Lithia Motors Price Target to $375 From $415 · Benzinga
- Morgan Stanley Trims Arch Capital Target to $105, Keeps Overweight · Benzinga
- Morgan Stanley Upgrades BorgWarner to Overweight, Target $95 · Benzinga
- Fed Probes Big Banks' Private-Credit Risk, Benzinga Says · Benzinga
- Barclays Bull Market Warning, Aramco Gas, Intel · Investing.com
- QQQ's 9:30 Candle Rises 0.09% on 2.5x Size (this story)
- RBC Raises HCA Healthcare Price Target to $496 From $435 · Benzinga
- Morgan Stanley Upgrades Cboe, Raises Price Target to $358 · Benzinga
- Morgan Stanley Nudges Two More Money Firms' Targets · Benzinga
- Barclays Rates SpaceX and Palantir Overweight · Seeking Alpha
From the archive: everything BBN aired on Wednesday, October 7, 2026 · the Your Money archive · all months


